yttrium radioisotopes has been researched along with Recrudescence in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (5.56) | 18.7374 |
| 1990's | 21 (29.17) | 18.2507 |
| 2000's | 32 (44.44) | 29.6817 |
| 2010's | 14 (19.44) | 24.3611 |
| 2020's | 1 (1.39) | 2.80 |
| Authors | Studies |
|---|---|
| Chrobok, A; Jabłońska, I; Jochymek, B; Matysiakiewicz, J; Miszczyk, L; Miszczyk, M; Mrożek, T; Spindel, J; Tomasik, P; Tukiendorf, A; Zakrzewski, T | 1 |
| Bellò, M; Benevolo, G; Bisi, G; Boccomini, C; Botto, B; Castellino, A; Chiappella, A; Ciochetto, C; Freilone, R; Nicolosi, M; Orsucci, L; Passera, R; Pecoraro, C; Pregno, P; Vitolo, U | 1 |
| Bron, D; de Wind, A; Golstein, SC; Muylle, K; Spilleboudt, C; Vercruyssen, M | 1 |
| Handa, H; Higuchi, T; Ishida, F; Ishizaki, T; Koiso, H; Matsumoto, M; Mitsui, T; Murakami, H; Ogura, H; Saitoh, T; Sakura, T; Shimizu, H; Takizawa, M; Toyama, K; Tsukamoto, N; Tsushima, Y; Yokohama, A | 1 |
| Allmer, C; Ansell, SM; Asmann, YW; Ballas, ZK; Colgan, JP; Gupta, M; Habermann, TM; Inwards, DJ; Johnston, PB; Link, BK; Maurer, MJ; Micallef, IN; Nowakowski, GS; Porrata, LF; Shanafelt, TD; Smith, BJ; Weiner, GJ; Wiseman, GA; Witzig, TE; Zent, CS | 1 |
| Calabrese, L; Crosta, C; Grana, C; Martinelli, G; Paganelli, G; Pinto, A; Pruneri, G; Radice, D; Rizzo, S; Vanazzi, A | 1 |
| Fine, S; Klestov, A | 1 |
| Bonner, WM; Brechbiel, MW; Brown, M; Bryant, BR; Carrasquillo, JA; Chen, C; Conlon, KC; Corcoran, E; Fioravanti, S; Fleisher, TA; Goldman, CK; Jaffe, ES; Janik, JE; Junghans, RP; Lee, CC; Lee, JH; Morris, JC; O'Mahony, D; Paik, CH; Pittaluga, S; Redon, CE; Stewart, DM; Waldmann, TA; Whatley, M; White, JD; Worthy, T | 1 |
| Kapetanos, GA; Kirkos, JM; Makris, V; Nikolaides, AP; Papavasiliou, KA; Symeonides, PP | 1 |
| Endo, K; Hayashi, M; Hotta, T; Ishizawa, K; Itoh, K; Matsuno, Y; Matsusako, M; Mori, S; Morishima, Y; Nakamura, S; Nawano, S; Ogura, M; Ohashi, Y; Okamoto, S; Okumura, H; Taniwaki, M; Terauchi, T; Tobinai, K; Tsukamoto, N; Watanabe, T | 1 |
| Gopal, AK; Winter, JN | 1 |
| Chen, J; Evens, AM; Gordon, LI; Hamilton, E; Helenowski, IB; Jovanovic, BD; Miller, RA; Miyata, S; Naumovski, L; Patton, D; Rosen, ST; Spies, S; Spies, WG; Variakojis, D; Winter, JN | 1 |
| Aebersold, DM; Greiner, RH; Pajic, B; Pajic-Eggspuehler, B; Vastardis, I | 1 |
| Burdick, MJ; Macklis, R; Neumann, D; Pohlman, B; Reddy, CA; Tendulkar, RD | 1 |
| Carpaneto, A; Cicone, F; Delaloye, AB; Ketterer, N; Prior, JO; Russo, E; Scopinaro, F | 1 |
| Illidge, T; Morschhauser, F | 1 |
| Alousi, AM; Anderlini, P; Bashir, Q; Champlin, RE; Ciurea, S; de Lima, M; Erwin, WD; Fowler, N; Gulbis, AM; Hosing, C; Kebriaei, P; Khouri, IF; Korbling, M; Macapinlac, HA; Medeiros, LJ; Neelapu, SS; Popat, UR; Saliba, RM; Samaniego, F; Samuels, BI; Valverde, R | 1 |
| Cilley, J; Evens, AM; Gallot, L; Gordon, LI; Larson, A; Patton, D; Rademaker, A; Roy, R; Spies, S; Variakojis, D; Winter, JN | 1 |
| Bulut, O; Gölge, UH; Günaydın, I; Korkmaz, M; Oztemür, Z; Oztürk, H; Tezeren, G | 1 |
| Betz, M; Delaloye, B; Farshad, M; Klammer, G; Peter, KP | 1 |
| Flusser, G; Isakov, J; Kollender, Y; Meller, I; Merimsky, O; Nyska, M; Shabat, S | 1 |
| Ajayi, BG; Bekibele, CO | 1 |
| Erwin, WD; Kornmehl, E; Leigh, B; Podoloff, DA; Sparks, RB; Spies, S; Stabin, MG; White, CA; Wiseman, GA; Witzig, T | 1 |
| de Feyter, PJ; Serruys, PW; Sianos, G; Wijns, W | 1 |
| Witzig, TE | 1 |
| Dühmke, E; Kantlehner, R; Klauss, V; König, A; Krötz, F; Pöllinger, B; Rieber, J; Schiele, TM; Seelig, V; Siebert, U; Sohn, HY; Theisen, K | 1 |
| Wiseman, GA; Witzig, TE | 1 |
| Anderson, AL; Dagis, A; Falk, P; Forman, S; Fung, H; Kirschbaum, M; Kogut, N; Krishnan, A; Kwok, C; Molina, A; Nademanee, A; Nakamura, R; O'donnell, M; Parker, P; Popplewell, L; Pullarkat, V; Raubitschek, A; Rodriguez, R; Sahebi, F; Smith, D; Smith, E; Snyder, D; Spielberger, R; Stein, A; White, C; Yamauchi, D; Zain, J | 1 |
| Gokhale, AS; Macklis, RM; Mayadev, J; Pohlman, B | 1 |
| Avril, N; Jacobs, SA; Joyce, J; McCook, B; Torok, F; Vidnovic, N | 1 |
| Blau, IW; Fietz, T; Gentilini, C; Glass, B; Marinets, O; Muessig, A; Munz, DL; Rieger, K; Sandrock, D; Thiel, E; Uharek, L | 1 |
| Endo, K; Hayashi, M; Igarashi, T; Itoh, K; Kobayashi, Y; Kusumoto, S; Nakata, M; Nawano, S; Sekiguchi, N; Seriu, T; Tanimoto, K; Terauchi, T; Terui, S; Tobinai, K; Usubuchi, N; Watanabe, T | 1 |
| Darif, M; Emmanouilides, C; Flinn, IW; Gordon, LI; Molina, A; Schilder, RJ; Vo, K; Wiseman, GA; Witzig, TE | 1 |
| Bonan, R; Fitzgerald, PJ; Honda, Y; Kaneda, H; Lansky, AJ; Morino, Y; Yock, PG | 1 |
| Ayala, E; Kharfan-Dabaja, MA; Raez, LE; Santos, ES | 1 |
| Dreyling, M; Hiddemann, W; Lang, N; Pastore, A; Rieken, M; Weigert, O | 1 |
| Hess, G; Huglo, D; Illidge, T; Kalmus, J; Liberati, AM; Marcus, R; Martinelli, G; Milpied, N; Morschhauser, F; Paganelli, G; Rule, S; Stein, H; Zinzani, PL | 1 |
| DeMonaco, NA; Jacobs, SA; Joyce, J; McCarty, KS | 1 |
| Ansell, SM; Habermann, TM; Inwards, DJ; Johnston, PB; Markovic, SN; Micallef, IN; Porrata, LF; Ristow, K; Tuinistra, N; Witzig, TE | 1 |
| Buriankova, E; Drymlova, J; Indrak, K; Kubova, Z; Kucerova, L; Myslivecek, M; Papajik, T; Prochazka, V; Raida, L | 1 |
| Decaudin, D; Djeridane, M; Kadouche, J; Levy, R; Lokiec, F; Morschhauser, F; Pecking, A | 1 |
| Backlund, EO; Bálint, K; Hajda, M; Julow, J; Lányi, F; Nyáry, I; Szeifert, GT | 1 |
| Abrey, LE; Divgi, CR; Humm, J; Iwamoto, FM; Pandit-Taskar, N; Peak, S; Schwartz, J; Zelenetz, AD | 1 |
| Wiss, DA | 1 |
| Belenger, J; Costa, M; Grob, E; Nouet, P; Popowski, Y; Redard, M; Rouzaud, M; Urban, P; Verin, V; Widmer, MC | 1 |
| Kurtz, JM; Nouet, P; Papirov, I; Popowski, Y; Rouzaud, M; Rutishauser, W; Schwager, M; Urban, P; Verin, V | 1 |
| Cipolla, GD; Crocker, IR; Gravanis, MB; Hillstead, RA; King, SB; Robinson, KA; Waksman, R; Wang, C | 1 |
| Grob, E; Kurtz, JM; Nouet, P; Papirov, I; Popowski, Y; Rouzaud, M; Rutishauser, W; Schwager, M; Urban, P; Verin, V | 1 |
| Collins, HA; Halpern, SE; Hupf, HB; Miller, RA; Parker, BA; Royston, I; Shawler, DL; White, CA | 1 |
| Amols, HI; Reinstein, LE; Weinberger, J | 1 |
| Popowski, Y; Urban, P; Verin, V | 1 |
| Kurtz, JM; Landis, JR; Nouet, P; Papirov, I; Popowski, Y; Rouzaud, M; Rutishauser, W; Schwager, M; Urban, P; Verin, V | 1 |
| Chatelain, P; Dorsaz, PA; Kurtz, JM; Nouet, P; Popowski, Y; Rutishauser, W; Schwager, M; Urban, P; Verin, V | 1 |
| Bijlsma, JW; Jacobs, JW; Jahangier, ZN; van Isselt, JW | 1 |
| Galindo, E; López-Cabarcos, C; Magallón, M; Rodríguez-Merchán, EC | 1 |
| Andersson, BS; Dicke, KA; Quadri, SM; Vriesendorp, HM; Wyllie, CT | 1 |
| Hopkins, K; Kemshead, JT; Papanastassiou, V; Zananiri, FA | 1 |
| Popowski, Y; Rutishauser, W; Urban, P; Verin, V | 1 |
| Becker, M; Chinn, P; Davis, T; Deb, N; Fowler, S; Goris, ML; Grillo-López, A; Knox, SJ; Levy, R; Liles, TM; Marquez, C; Negrin, R; Ning, SC; Trisler, K; Varns, C | 1 |
| Bauer, A; Gielow, A; Schneider, A; Schöfer, H; Silber, S; von Rottkay, P | 1 |
| Menkes, C; Molho, P; Ounnoughène, N; Schacher, JM; Stieltjes, N; Sultan, Y; Vassilieff, D; Verrier, P | 1 |
| Emmanouilides, C; Gordon, LI; Grillo-López, AJ; Gutheil, J; Janakiraman, N; Raubitschek, A; Schilder, RJ; Silverman, DH; Spies, S; White, CA; Wiseman, GA; Witzig, TE | 1 |
| Alavi, A; Goldenberg, DM; Hajjar, G; Juweid, ME; Luger, S; Sharkey, RM; Stadtmauer, E; Suleiman, S; Swayne, LC | 1 |
| Emmanouilides, C; Gordon, LI; Grillo-López, AJ; Gutheil, J; Janakiraman, N; Parker, E; Raubitschek, A; Schilder, RJ; Silverman, DH; Spies, S; White, CA; Wiseman, GA; Witzig, TE | 1 |
| Bhargava, B; Chan, RC; Kent, KK; Lansky, AJ; Leon, MB; Mehran, R; Mintz, GS; Pichard, AD; Satler, LF; Waksman, R; White, L | 1 |
| Bhargava, B; Chan, RC; Lansky, AJ; Mehran, R; Mintz, GS; Waksman, R; Walsh, C; Weissman, NJ | 1 |
| Baumgart, D; Erbel, R; Haude, M; Kaiser, CA; Naber, CK; Rahman, YA | 1 |
| Aras, G; Ataman, S; Atay, G; Gencoglu, EA; Ibis, E; Kucuk, O; Soylu, A; Tutak, I | 1 |
| Payer, H | 1 |
| Oka, M | 1 |
| Deka, AC; Deka, BC; Rao, SM; Supe, SJ; Supe, SS | 1 |
| Beguin, J; Guaydier-Souquieres, C; Loyau, G; Ollivier, D | 1 |
7 review(s) available for yttrium radioisotopes and Recrudescence
| Article | Year |
|---|---|
Radioimmunoconjugates in hematopoietic stem cell transplantation.
Topics: Disease-Free Survival; Dose-Response Relationship, Radiation; Hematopoietic Stem Cell Transplantation; Humans; Immunoconjugates; Iodine Radioisotopes; Lymphoma; Neoplasms; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2009 |
Radioimmunotherapy in follicular lymphoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Humans; Lymphoma, Follicular; Mice; Radioimmunotherapy; Recurrence; Remission Induction; Risk Factors; Rituximab; Sialic Acid Binding Ig-like Lectin 2; Yttrium Radioisotopes | 2011 |
Efficacy and safety of 90Y ibritumomab tiuxetan (Zevalin) radioimmunotherapy for non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antigens, CD20; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Recurrence; Risk Factors; Thrombocytopenia; Yttrium Radioisotopes | 2003 |
Current results and future applications of radioimmunotherapy management of non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Iodine Radioisotopes; Lymphoma, Non-Hodgkin; Radioimmunotherapy; Radiometry; Recurrence; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2006 |
[Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany].
Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Coronary Disease; Equipment Design; Germany; Half-Life; Humans; Multicenter Studies as Topic; Recurrence; Retreatment; Stents; Strontium Radioisotopes; Treatment Outcome; Yttrium Radioisotopes | 1998 |
Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
Topics: Antibodies, Monoclonal; Antigens, CD20; Humans; Lymphoma, Non-Hodgkin; Pentetic Acid; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes | 1999 |
Treatment of keloids by 90Sr-90Y beta-rays.
Topics: Adolescent; Adult; Aged; Beta Particles; Child; Combined Modality Therapy; Female; Humans; Keloid; Male; Middle Aged; Postoperative Care; Radiotherapy Dosage; Recurrence; Strontium Radioisotopes; Time Factors; Yttrium Radioisotopes | 1991 |
23 trial(s) available for yttrium radioisotopes and Recrudescence
| Article | Year |
|---|---|
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Invasiveness; Podophyllotoxin; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2018 |
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; B-Lymphocytes; Drug Administration Schedule; Humans; Immunologic Factors; Interleukin-10; Interleukin-1beta; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oligodeoxyribonucleotides; Radioimmunotherapy; Radiopharmaceuticals; Recurrence; Survival Analysis; Tumor Necrosis Factor-alpha; Yttrium Radioisotopes | 2013 |
Efficacy of ⁹⁰Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prospective Studies; Radioimmunotherapy; Recurrence; Rituximab; Salvage Therapy; Stomach Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes | 2009 |
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Metalloporphyrins; Middle Aged; Porphyrins; Radiation-Sensitizing Agents; Radioimmunotherapy; Recurrence; Treatment Outcome; Yttrium Radioisotopes | 2009 |
External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Cell Count; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Platelet Count; Positron-Emission Tomography; Radiotherapy; Radiotherapy Dosage; Recurrence; Tomography, X-Ray Computed; Tumor Burden; Yttrium Radioisotopes | 2011 |
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Topics: Adult; Aged; Antibodies, Monoclonal; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Follicular; Male; Middle Aged; Myeloablative Agonists; Radioimmunotherapy; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Yttrium Radioisotopes | 2012 |
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Boronic Acids; Bortezomib; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Pyrazines; Radioimmunotherapy; Recurrence; Treatment Outcome; Yttrium Radioisotopes | 2013 |
The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints.
Topics: Adolescent; Adult; Ankle Joint; Arthrography; Combined Modality Therapy; Female; Follow-Up Studies; Hip Joint; Humans; Injections, Intra-Articular; Knee Joint; Magnetic Resonance Imaging; Male; Radionuclide Imaging; Recurrence; Synovectomy; Synovial Membrane; Synovitis, Pigmented Villonodular; Yttrium Radioisotopes | 2002 |
Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Bone Marrow; Half-Life; Humans; Immunoconjugates; Indium Radioisotopes; Kidney; Lymphoma, Non-Hodgkin; Middle Aged; Radiation Dosage; Radioimmunotherapy; Radiotherapy Dosage; Recurrence; Rituximab; Tissue Distribution; Yttrium Radioisotopes | 2003 |
Geographical miss during centered intracoronary beta-radiation with 90Yttrium: incidence and implications for recurrence rates after vascular brachytherapy for de novo lesions.
Topics: Brachytherapy; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Female; Humans; Incidence; Male; Middle Aged; Prospective Studies; Radiotherapy Dosage; Recurrence; Retrospective Studies; Yttrium Radioisotopes | 2003 |
A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma.
Topics: Adult; Antibodies, Monoclonal; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radioimmunotherapy; Recurrence; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Yttrium Radioisotopes | 2005 |
Full-dose 90Y ibritumomab tiuxetan therapy is safe in patients with prior myeloablative chemotherapy.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal; Antigens, CD20; Blood Platelets; Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Platelet Count; Pleural Effusion; Positron-Emission Tomography; Radioimmunotherapy; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Dose-Response Relationship, Radiation; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Staging; Radioimmunotherapy; Recurrence; Reproducibility of Results; Tissue Distribution; Yttrium Radioisotopes | 2005 |
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes | 2007 |
Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody.
Topics: Adult; Antibodies, Monoclonal; Cohort Studies; Female; Ferritins; Hodgkin Disease; Humans; Immunoconjugates; Male; Neoplasm Staging; Radioimmunotherapy; Recurrence; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma.
Topics: Aged; Central Nervous System Neoplasms; Disease-Free Survival; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Radioimmunotherapy; Radiotherapy Dosage; Recurrence; Survival Rate; Yttrium Radioisotopes | 2007 |
Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Angioplasty, Balloon, Coronary; Beta Particles; Brachytherapy; Combined Modality Therapy; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Recurrence; Stents; Time Factors; Yttrium Radioisotopes | 1997 |
Persistent synovitis treated with radiation synovectomy using yttrium-90: a retrospective evaluation of 83 procedures for 45 patients.
Topics: Adolescent; Adult; Aged; Chronic Disease; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Radiosurgery; Recurrence; Reoperation; Retrospective Studies; Survival Analysis; Synovectomy; Synovitis; Treatment Outcome; Yttrium Radioisotopes | 1997 |
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; B-Lymphocytes; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioimmunotherapy; Recurrence; Rituximab; Yttrium Radioisotopes | 1999 |
Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Beta Particles; Brachytherapy; Constriction, Pathologic; Coronary Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Recurrence; Stents; Tunica Intima; Yttrium Radioisotopes | 2000 |
Serial volumetric intravascular ultrasound analysis of the efficacy of beta irradiation in preventing recurrent in-stent restenosis.
Topics: Beta Particles; Brachytherapy; Coronary Disease; Follow-Up Studies; Humans; Iridium Radioisotopes; Recurrence; Stents; Time Factors; Ultrasonography, Interventional; Yttrium Radioisotopes | 2000 |
Utility of Tc-99m human polyclonal immunoglobulin G scintigraphy for assessing the efficacy of yttrium-90 silicate therapy in rheumatoid knee synovitis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Chronic Disease; Female; Follow-Up Studies; Humans; Immunoglobulins; Knee Joint; Male; Middle Aged; Radionuclide Imaging; Recurrence; Severity of Illness Index; Silicates; Synovitis; Technetium; Treatment Outcome; Yttrium Radioisotopes | 2002 |
42 other study(ies) available for yttrium radioisotopes and Recrudescence
| Article | Year |
|---|---|
The results of 394 consecutive cases of knee joint radiation synovectomy (radiosynoviorthesis) using
Topics: Arthritis, Rheumatoid; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Knee Joint; Male; Middle Aged; Pain; Pain Management; Range of Motion, Articular; Recurrence; Retrospective Studies; Synovectomy; Synovitis, Pigmented Villonodular; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Long-term follow-up of 2 patients treated with
Topics: Adult; Biopsy; Follow-Up Studies; Hodgkin Disease; Humans; Immunohistochemistry; Lymphocytes; Male; Positron Emission Tomography Computed Tomography; Radioimmunotherapy; Recurrence; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2018 |
Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy.
Topics: Antibodies, Monoclonal; Diagnostic Imaging; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Remission Induction; Retrospective Studies; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2019 |
Recurrent Hemarthroses After TKA Treated With an Intraarticular Injection of Yttrium-90.
Topics: Aged, 80 and over; Arthroplasty, Replacement, Knee; Female; Hemarthrosis; Humans; Injections, Intra-Articular; Postoperative Complications; Recurrence; Yttrium Radioisotopes | 2016 |
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Daclizumab; Female; Hodgkin Disease; Humans; Immunoglobulin G; Interleukin-2 Receptor alpha Subunit; Male; Middle Aged; Phosphorylation; Recurrence; Young Adult; Yttrium Radioisotopes | 2015 |
Recurrent spontaneous hemarthrosis after total knee arthroplasty successfully treated with synoviorthesis.
Topics: Arthroplasty, Replacement, Knee; Female; Hemarthrosis; Humans; Hypertrophy; Middle Aged; Recurrence; Synovial Membrane; Yttrium Radioisotopes | 2008 |
Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up.
Topics: Adult; Aged; Aged, 80 and over; Astigmatism; Beta Particles; Brachytherapy; Esthetics; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pterygium; Radiotherapy Dosage; Recurrence; Retreatment; Strontium Radioisotopes; Visual Acuity; Yttrium Radioisotopes | 2009 |
Follicular lymphoma at relapse after rituximab containing regimens: comparison of time to event intervals prior to and after 90 Y-ibritumomab-tiuxetan.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Staging; Radioimmunotherapy; Recurrence; Retrospective Studies; Rituximab; Yttrium Radioisotopes | 2011 |
Surgical synovectomy combined with yttrium 90 in patients with recurrent joint synovitis.
Topics: Adult; Arthroscopy; Biopsy; Female; Humans; Knee Joint; Male; Middle Aged; Pain Measurement; Patient Satisfaction; Predictive Value of Tests; Radiopharmaceuticals; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Synovitis; Time Factors; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2013 |
Bilateral diffuse pigmented villonodular synovitis of the knee.
Topics: Adolescent; Female; Humans; Knee Joint; Magnetic Resonance Imaging; Recurrence; Synovectomy; Synovial Membrane; Synovitis, Pigmented Villonodular; Yttrium Radioisotopes | 2013 |
Evaluation of the effectiveness of post-operative beta-irradiation in the management of pterygium.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Beta Particles; Child; Female; Humans; Male; Middle Aged; Occupational Exposure; Occupations; Postoperative Care; Pterygium; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Strontium Radioisotopes; Sunlight; Treatment Outcome; Visual Acuity; Yttrium Radioisotopes | 2002 |
Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions.
Topics: Actuarial Analysis; Aged; Brachytherapy; Coronary Angiography; Endothelium, Vascular; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Strontium Radioisotopes; Time Factors; Yttrium Radioisotopes | 2004 |
Yttrium-90 (90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-Cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD20; Disease Progression; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioimmunotherapy; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD20; Disease Progression; Female; Gamma Cameras; Humans; Indium Radioisotopes; Lymphoma, B-Cell; Male; Middle Aged; Prognosis; Radioimmunotherapy; Radionuclide Imaging; Recurrence; Treatment Outcome; Yttrium Radioisotopes | 2005 |
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Cyclophosphamide; Disease Progression; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Radioimmunotherapy; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Yttrium Radioisotopes | 2006 |
Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Female; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Recurrence; Remission Induction; Yttrium Radioisotopes | 2006 |
Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Beta Particles; Blood Vessel Prosthesis Implantation; Brachytherapy; Coronary Angiography; Coronary Artery Bypass; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recurrence; Stents; Strontium Radioisotopes; Treatment Outcome; Ultrasonography, Interventional; Yttrium Radioisotopes | 2006 |
Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Mitoxantrone; Prednisone; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Radioimmunotherapy; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Vidarabine; Vincristine; Yttrium Radioisotopes | 2007 |
Focal radiation fibrosis after radioimmunotherapy for follicular non-Hodgkin lymphoma.
Topics: Aged; Antibodies, Monoclonal; Diagnosis, Differential; Dose-Response Relationship, Radiation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Pneumonitis; Radioimmunotherapy; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Lymphocyte Count; Lymphoma, Follicular; Male; Middle Aged; Prognosis; Radioimmunotherapy; Recurrence; Rituximab; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes | 2007 |
Relapsed follicular lymphoma sequentially treated with rituximab and 90Y-ibritumomab tiuxetan. Case report.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Female; Humans; Lymphoma, Follicular; Radioimmunotherapy; Recurrence; Rituximab; Yttrium Radioisotopes | 2007 |
Long-term results and late complications after intracavitary yttrium-90 colloid irradiation of recurrent cystic craniopharyngiomas.
Topics: Adolescent; Adult; Aged; Brachytherapy; Child; Child, Preschool; Colloids; Combined Modality Therapy; Craniopharyngioma; Cysts; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pituitary Neoplasms; Radiosurgery; Radiotherapy Dosage; Recurrence; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2007 |
Recurrent villonodular synovitis of the knee. Successful treatment with yttrium-90.
Topics: Biopsy; Female; Humans; Injections, Intra-Articular; Knee Joint; Middle Aged; Recurrence; Synovial Membrane; Synovitis; Synovitis, Pigmented Villonodular; Yttrium Radioisotopes | 1982 |
Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model.
Topics: Angioplasty, Balloon; Animals; Brachytherapy; Carotid Arteries; Constriction, Pathologic; Dose-Response Relationship, Radiation; Feasibility Studies; Female; Hypercholesterolemia; Hyperplasia; Iliac Artery; Male; Rabbits; Recurrence; Tunica Intima; Yttrium Radioisotopes | 1995 |
Intra-arterial 90Y brachytherapy: preliminary dosimetric study using a specially modified angioplasty balloon.
Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Equipment Design; Radiotherapy Dosage; Recurrence; Yttrium Radioisotopes | 1995 |
Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model.
Topics: Angioplasty, Balloon, Coronary; Animals; Beta Particles; Brachytherapy; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Radiation; Female; Microscopy, Electron, Scanning; Radiotherapy Dosage; Recurrence; Strontium Radioisotopes; Swine; Tunica Intima; Yttrium Radioisotopes | 1995 |
High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation.
Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Coronary Artery Disease; Models, Anatomic; Radiation Protection; Radiotherapy Dosage; Recurrence; Yttrium Radioisotopes | 1995 |
Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Radiography; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes | 1996 |
Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia.
Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Combined Modality Therapy; Coronary Disease; Coronary Vessels; Humans; Hyperplasia; Muscle, Smooth, Vascular; Recurrence; Tunica Intima; Yttrium Radioisotopes | 1996 |
Endovascular beta-irradiation after percutaneous transluminal coronary balloon angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Brachytherapy; Combined Modality Therapy; Coronary Disease; Feasibility Studies; Female; Humans; Male; Pilot Projects; Radiation Protection; Radiotherapy Dosage; Recurrence; Yttrium Radioisotopes | 1996 |
A novel system for intracoronary beta-irradiation: description and dosimetric results.
Topics: Brachytherapy; Coronary Disease; Humans; Radiotherapy Dosage; Recurrence; Stents; Yttrium Radioisotopes | 1996 |
Hemophilic synovitis of the knee and the elbow.
Topics: Adolescent; Adult; Arthroscopy; Child; Chronic Disease; Disease Progression; Elbow Joint; Endoscopy; Factor VIII; Follow-Up Studies; Gold Radioisotopes; Hemarthrosis; Hemophilia A; Humans; Injections, Intra-Articular; Joint Diseases; Knee Joint; Prospective Studies; Radiography; Radiopharmaceuticals; Radius; Recurrence; Synovectomy; Synovitis; Treatment Outcome; Yttrium Radioisotopes | 1997 |
Recurrence of Hodgkin's disease after indium-111 and yttrium-90 labeled antiferritin administration.
Topics: Ferritins; Hodgkin Disease; Humans; Indium Radioisotopes; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes | 1997 |
A model to estimate the dose to tumour following intracavity administration of radioimmunoconjugates to patients with malignant gliomas.
Topics: Antibodies, Monoclonal; Glioma; Humans; Immunoconjugates; Iodine Radioisotopes; Models, Biological; Neural Cell Adhesion Molecules; Radiation Dosage; Radioimmunotherapy; Recurrence; Yttrium Radioisotopes | 1997 |
Feasibility and safety of beta irradiation in human coronary arteries.
Topics: Angioplasty, Balloon, Coronary; Animals; Brachytherapy; Carotid Arteries; Coronary Disease; Coronary Vessels; Dose-Response Relationship, Radiation; Feasibility Studies; Follow-Up Studies; Humans; Iliac Artery; Rabbits; Radiation Protection; Recurrence; Stents; Time Factors; Yttrium Radioisotopes | 1997 |
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antigens, CD20; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Radioimmunotherapy; Radiotherapy Dosage; Recurrence; Tissue Distribution; Yttrium Radioisotopes | 1996 |
A retrospective study on chemical and radioactive synovectomy in severe haemophilia patients with recurrent haemarthrosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Hemarthrosis; Hemophilia A; Humans; Injections, Intra-Articular; Middle Aged; Osmium Tetroxide; Radioisotopes; Radiopharmaceuticals; Recurrence; Retrospective Studies; Synovectomy; Yttrium Radioisotopes | 1999 |
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
Topics: Adult; Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lectins; Lymphoma, Non-Hodgkin; Male; Mice; Middle Aged; Radioimmunotherapy; Radiotherapy Dosage; Recurrence; Sialic Acid Binding Ig-like Lectin 2; Yttrium Radioisotopes | 1999 |
[Late stent thrombosis after intracoronary brachytherapy. A case report and review of the literature].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Brachytherapy; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; Electrocardiography; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Stents; Strontium Radioisotopes; Thrombosis; Ticlopidine; Time Factors; Ultrasonography, Interventional; Yttrium Radioisotopes | 2001 |
[Results of the 90Sr- and 90Y-radiation after surgical removal of 123 pterygia (author's transl)].
Topics: Adult; Female; Humans; Male; Middle Aged; Pterygium; Recurrence; Strontium Radioisotopes; Yttrium Radioisotopes | 1979 |
Radiation synovectomy of the rheumatoid knee with yttrium 90.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Evaluation Studies as Topic; Follow-Up Studies; Humans; Injections, Intra-Articular; Middle Aged; Osmium; Radiotherapy Dosage; Recurrence; Synovial Membrane; Yttrium Radioisotopes | 1975 |
Knee arthroscopy after yttrium or osmic acid injection.
Topics: Adolescent; Adult; Aged; Arthritis, Rheumatoid; Arthroscopy; Child; Female; Follow-Up Studies; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Osmium; Osmium Tetroxide; Recurrence; Synovial Membrane; Synovitis; Yttrium Radioisotopes | 1989 |